The stock of x-ray digitization firm Swissray International hasbeen approved for listing on the NASDAQ stock exchange's small-capbulletin board under the symbol SRMI. Swissray, of Hitzkirch,Switzerland, is developing Add-On Bucky, a device that
The stock of x-ray digitization firm Swissray International has
been approved for listing on the NASDAQ stock exchange's small-cap
bulletin board under the symbol SRMI. Swissray, of Hitzkirch,
Switzerland, is developing Add-On Bucky, a device that retrofits
to conventional x-ray systems for x-ray digitization (SCAN 12/13/95).
Swissray's stock was trading at about $4.75 a share last week.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.